Back to Journals » Therapeutics and Clinical Risk Management » Volume 5

Therapeutics and Clinical Risk Management


Archive: Volume 5, 2009

In-hospital resuscitation: opioids and other factors influencing survival

Karamarie Fecho, Freeman Jackson, Frances Smith, et al

Therapeutics and Clinical Risk Management 2009, 5:961-968

Published Date: 8 December 2009

Monitored anesthesia care (MAC) sedation: clinical utility of fospropofol

Eric A Harris, David A Lubarsky, Keith A Candiotti

Therapeutics and Clinical Risk Management 2009, 5:949-959

Published Date: 8 December 2009

The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab

Richard Kelly, Stephen Richards, Peter Hillmen, et al

Therapeutics and Clinical Risk Management 2009, 5:911-921

Published Date: 18 November 2009

Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability

Andre R Brunoni, Renerio Fraguas Jr, Felipe Fregni

Therapeutics and Clinical Risk Management 2009, 5:897-910

Published Date: 17 November 2009

Update on the use of deferasirox in the management of iron overload

Ali Taher, Maria Domenica Cappellini

Therapeutics and Clinical Risk Management 2009, 5:857-868

Published Date: 30 October 2009

Pediatric psoriasis: an update

Nanette B Silverberg

Therapeutics and Clinical Risk Management 2009, 5:849-856

Published Date: 21 October 2009

The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea

Hoonmo L Koo, Herbert L DuPont, David B Huang

Therapeutics and Clinical Risk Management 2009, 5:841-848

Published Date: 21 October 2009

The role of urate and xanthine oxidase in vascular oxidative stress: future directions

Jacob George, Allan Struthers

Therapeutics and Clinical Risk Management 2009, 5:799-803

Published Date: 5 October 2009

Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer

Serena Ricciardi, Silverio Tomao, Filippo de Marinis

Therapeutics and Clinical Risk Management 2009, 5:781-787

Published Date: 25 September 2009

Dyslipidemia in Iranian overweight and obese children

Robabeh Ghergerehchi

Therapeutics and Clinical Risk Management 2009, 5:739-743

Published Date: 18 September 2009

Anticholinergic syndrome following an unintentional overdose of scopolamine

Carmela E Corallo, Ann Whitfield, Adeline Wu

Therapeutics and Clinical Risk Management 2009, 5:719-723

Published Date: 13 September 2009

Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review

S Deandrea, O Corli, I Moschetti, et al

Therapeutics and Clinical Risk Management 2009, 5:707-718

Published Date: 4 September 2009

Role of everolimus in the treatment of renal cell carcinoma

Saby George, Ronald M Bukowski

Therapeutics and Clinical Risk Management 2009, 5:699-706

Published Date: 28 August 2009

Incretin-based therapies: new treatments for type 2 diabetes in the new millennium

Joan Khoo, Christopher K Rayner, Karen L Jones, et al

Therapeutics and Clinical Risk Management 2009, 5:683-698

Published Date: 20 August 2009

Managing pediatric hepatitis C: current and emerging treatment options

Wikrom Karnsakul, Mary Kay Alford, Kathleen B Schwarz

Therapeutics and Clinical Risk Management 2009, 5:651-660

Published Date: 13 August 2009

Pegylated liposomal doxorubicin in ovarian cancer

Robert Strother, Daniela Matei

Therapeutics and Clinical Risk Management 2009, 5:639-650

Published Date: 10 August 2009

Epileptic seizure after treatment with thiocolchicoside

Pedro Giavina-Bianchi, Mara Giavina-Bianchi, Luciana Kase Tanno, et al

Therapeutics and Clinical Risk Management 2009, 5:635-637

Published Date: 6 August 2009

Parenteral clevidipine for the acute control of blood pressure in the critically ill patient: a review

W Frank Peacock IV, Jorge E Angeles, Karina M Soto, et al

Therapeutics and Clinical Risk Management 2009, 5:627-634

Published Date: 4 August 2009

Current trends in the treatment of hepatic encephalopathy

Mohamad Rasm Al Sibae, Brendan M McGuire

Therapeutics and Clinical Risk Management 2009, 5:617-626

Published Date: 31 July 2009

Natalizumab in the treatment of multiple sclerosis

Brandon A Brown

Therapeutics and Clinical Risk Management 2009, 5:585-594

Published Date: 31 July 2009

Management strategies for pulmonary sarcoidosis

Robina Kate Coker

Therapeutics and Clinical Risk Management 2009, 5:575-584

Published Date: 23 July 2009

A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers

Seyed Ali Sadjadi, James I McMillan, Navin Jaipaul, Patricia Blakely, et al.

Therapeutics and Clinical Risk Management 2009, 5:547-552

Published Date: 10 July 2009

Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis

Devi Mukkai Krishnamurty, Atoosa Rabiee, Sanjay B Jagannath, Dana K Andersen

Therapeutics and Clinical Risk Management 2009, 5:507-520

Published Date: 2 July 2009

Does nonadherence to local recommendations for empirical antibiotic therapy on admission to the intensive care unit have an impact on in-hospital mortality?

Jean-Luc Baudel, Jacques Tankovic, Fabrice Carrat, Cécile Vigneau, et al.

Therapeutics and Clinical Risk Management 2009, 5:491-498

Published Date: 9 July 2009

Guidelines for the treatment of bacterial vaginosis: focus on tinidazole

Laura J Dickey, Michael D Nailor, Jack D Sobel

Therapeutics and Clinical Risk Management 2009, 5:485-489

Published Date: 23 June 2009

Substitution of anticonvulsant drugs

Bernhard J Steinhoff, Uwe Runge, Otto W Witte, Hermann Stefan, et al.

Therapeutics and Clinical Risk Management 2009, 5:449-457

Published Date: 22 June 2009

The benefits and risks of testosterone replacement therapy: a review

Nazem Bassil, Saad Alkaade, John E Morley

Therapeutics and Clinical Risk Management 2009, 5:427-448

Published Date: 11 June 2009

Treatment of recurrent epithelial ovarian cancer

Carmela Pisano, Giovanni S Bruni, Gaetano Facchini, Claudia Marchetti, et al.

Therapeutics and Clinical Risk Management 2009, 5:421-426

Published Date: 15 June 2009

Minimizing cardiac surgery risks in a Hepatitis C patient: Changing surgical strategy after evaluation by modern imaging technologies

Felix Kur, Andres Beiras-Fernandez, Martin Oberhoffer, Konstantin Nikolaou, et al.

Therapeutics and Clinical Risk Management 2009, 5:409-412

Published Date: 21 May 2009

Managing Behçet’s disease: An update on current and emerging treatment options

P LA van Daele, J H Kappen, P M van Hagen, J AM van Laar

Therapeutics and Clinical Risk Management 2009, 5:385-390

Published Date: 13 May 2009

Fatty liver in children

Mandana Rafeey, Fakhrossadat Mortazavi, Nafiseh Mogaddasi, Ghergherehchi Robabeh, et al.

Therapeutics and Clinical Risk Management 2009, 5:371-374

Published Date: 8 May 2009

Once-daily medications for the pharmacological management of ADHD in adults

Oleg v Tcheremissine, Lori M Lieving

Therapeutics and Clinical Risk Management 2009, 5:367-369

Published Date: 11 May 2009

Anthracycline extravasation injuries: management with dexrazoxane

Karin Jordan, Timo Behlendorf, Franziska Mueller, Hans-Joachim Schmoll

Therapeutics and Clinical Risk Management 2009, 5:361-366

Published Date: 8 May 2009

Current trends in the treatment of polycystic ovary syndrome with desire for children

Margalida E Sastre, Maria O Prat, Miguel Angel Checa, Ramon C Carreras

Therapeutics and Clinical Risk Management 2009, 5:353-360

Published Date: 8 May 2009

Associations of anemia persistency with medical expenditures in Medicare ESRD patients on dialysis

Jiannong Liu, Haifeng Guo, David Gilbertson, Robert Foley, et al.

Therapeutics and Clinical Risk Management 2009, 5:319-330

Published Date: 22 April 2009

Antimalarials and the fight against malaria in Brazil

Luiz MA Carmargo, Saulo de Oliveira, Sergio Basano, Célia RS Garcia

Therapeutics and Clinical Risk Management 2009, 5:311-317

Published Date: 22 April 2009

Management of glucocorticoids-induced osteoporosis: role of teriparatide

Silvia Migliaccio, Marina Brama, Nazzarena Malavolta

Therapeutics and Clinical Risk Management 2009, 5:305-310

Published Date: 17 April 2009

Cecal perforation with an ascending colon cancer caused by upper gastrointestinal endoscopy

Hiroyuki Miyatani, Yukio Yoshida, Hirokazu Kiyozaki

Therapeutics and Clinical Risk Management 2009, 5:301-303

Published Date: 3 April 2009

Dasatinib in chronic myeloid leukemia: a review

Dolly G Aguilera, Apostolia M Tsimberidou

Therapeutics and Clinical Risk Management 2009, 5:281-289

Published Date: 27 March 2009

Onset of action and seizure control in Lennox-Gaustaut syndrome: focus on rufinamide

Russell P Saneto, Gail D Anderson

Therapeutics and Clinical Risk Management 2009, 5:271-280

Published Date: 26 March 2009

Recombinant human epoetin beta in the treatment of chemotherapy-related anemia

Iain RJ Macpherson, Colin R Lindsay, Nicholas S Reed

Therapeutics and Clinical Risk Management 2009, 5:261-270

Published Date: 16 March 2009

Incidence and causes of neonatal hyperbilirubinemia in a center of Catania

Marco Sciuto, Gaetano Bertino, Mariangela Zocco, Ignazio Vecchio, et al.

Therapeutics and Clinical Risk Management 2009, 5:247-250

Published Date: 12 March 2009

Challenging issues in molecular-targeted therapy

Zoheir Ezziane

Therapeutics and Clinical Risk Management 2009, 5:239-245

Published Date: 3 March 2009

Role of oxaliplatin in the treatment of colorectal cancer

Pasquale Comella, Rossana Casaretti, Claudia Sandomenico, Antonio Avallone, Luca Franco

Therapeutics and Clinical Risk Management 2009, 5:229-238

Published Date: 4 March 2009

Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations

Alberto Borgioli, Christian Viviani, Marco Duvina, Leila Brancato, Giuseppe Spinelli, et al

Therapeutics and Clinical Risk Management 2009, 5:217-227

Published Date: 27 February 2009

Regimen complexity and medication nonadherence in elderly patients

Andrea Corsonello, Claudio Pedone, Fabrizia Lattanzio, Maria Lucchetti, Sabrina Garasto, et al.

Therapeutics and Clinical Risk Management 2009, 5:209-216

Published Date: 26 February 2009

Fludarabine in the treatment of chronic lymphocytic leukemia: a review

Francesca Ricci, Alessandra Tedeschi, Enrica Morra, Marco Montillo

Therapeutics and Clinical Risk Management 2009, 5:187-207

Published Date: 4 March 2009

Tenofovir and its potential in the treatment of hepatitis B virus

Laura Reynaud, Maria Aurora Carleo, Maria Talamo, Guglielmo Borgia

Therapeutics and Clinical Risk Management 2009, 5:177-185

Published Date: 2 February 2009

Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection

Pranav Dalal, Monica Grafals, Darshika Chhabra, Lorenzo Gallon

Therapeutics and Clinical Risk Management 2009, 5:139-149

Published Date: 13 January 2009

Nd: YAG capsulotomy for posterior capsule opacification after combined clear corneal phacoemulsification and vitrectomy

Ilias Georgalas, Petros Petrou, George Kalantzis, Dimitrios Papaconstantinou, Chrysanthi Koutsandrea, Ioannis Ladas

Therapeutics and Clinical Risk Management 2009, 5:133-137

Published Date: 11 January 2009

Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses

Hideki Hasegawa, Takeshi Ichinohe, Akira Ainai, Shin-ichi Tamura, Takeshi Kurata

Therapeutics and Clinical Risk Management 2009, 5:125-132

Published Date: 9 March 2009

Role of atazanavir in the treatment of HIV infection

Pablo Rivas, Judit Morello, Carolina Garrido, Sonia Rodríguez-Nóvoa, Vincent Soriano

Therapeutics and Clinical Risk Management 2009, 5:99-116

Published Date: 17 December 2008

A review of the use of exemestane in early breast cancer

Andrew Robinson

Therapeutics and Clinical Risk Management 2009, 5:91-98

Published Date: 11 December 2008

Angioid streaks, clinical course, complications, and current therapeutic management

Ilias Georgalas, Dimitris Papaconstantinou, Chrysanthi Koutsandrea, George Kalantzis, Dimitris Karagiannis, et al

Therapeutics and Clinical Risk Management 2009, 5:81-89

Published Date: 9 December 2008

Life-threatening hemorrhage following subcutaneous heparin therapy

Jana Hudcova, Daniel Talmor

Therapeutics and Clinical Risk Management 2009, 5:51-54

Published Date: 2 December 2008

Topical retapamulin in the management of infected traumatic skin lesions

Ribhi Shawar, Nicole Scangarella-Oman, MaryBeth Dalessandro, John Breton, Monique Twynholm, et al

Therapeutics and Clinical Risk Management 2009, 5:41-49

Published Date: 4 December 2008

Management of postoperative nausea and vomiting: focus on palonosetron

Neil A Muchatuta, Michael J Paech

Therapeutics and Clinical Risk Management 2009, 5:21-34

Published Date: 30 November 2008

Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab

Ilias Georgalas, Dimitris Papaconstantinou, Ioannis Tservakis, Chrysanthi Koutsandrea, Ioannis Ladas

Therapeutics and Clinical Risk Management 2009, 5:17-19

Published Date: 27 November 2008

Regular use of traditional analgesics predicts major coronary events: A cohort study

Mikko Haara, Markku Heliövaara, Jari PA Arokoski, Paul Knekt, Pirjo Manninen, et al

Therapeutics and Clinical Risk Management 2009, 5:9-15

Published Date: 2 December 2008